PoltregWAR:PTG +1.86%46 PB Ratio is 2.44 as of Jul. 11, 2026, which is 3% below its 10-year median of 2.51. GuruFocus rates WAR:PTG with a GF Score™ of 46/100 and a GF Value™ of zł14.20 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,227 Biotechnology companies, Poltreg ranks better than 58.44% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-11), Poltreg's share price is zł19.15. Poltreg's Book Value per Share for the quarter that ended in Mar. 2026 was zł7.85. Hence, Poltreg's PB Ratio of today is 2.44.
The historical rank and industry rank for Poltreg's PB Ratio or its related term are showing as below:
WAR:PTG'
s PB Ratio Range Over the Past 10 Years
Min: 1.39 Med: 2.51 Max: 3.42
Current: 2.43
During the past 8 years, Poltreg's highest PB Ratio was 3.42. The lowest was 1.39. And the median was 2.51.
WAR:PTG's PB Ratio is ranked better than 58.44% of 1227
companies
in the Biotechnology industry
Industry Median: 2.95
vs WAR:PTG: 2.43
During the past 12 months, Poltreg's average Book Value Per Share Growth Rate was -42.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -24.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.10% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Poltreg was 375.80% per year. The lowest was -24.60% per year. And the median was 26.95% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Poltreg PB Ratio Related Terms
Poltreg PB Ratio Historical Data
* Premium members only.
The historical data trend for Poltreg's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Poltreg's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Poltreg PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Poltreg's PB Ratio distribution charts can be found below:
* The bar in red indicates where Poltreg's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Poltreg's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Poltreg (WAR:PTG) has a PB Ratio of 2.44 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Poltreg and its competitors. This is near median its historical median of 2.51. Over the past decade, Poltreg's PB Ratio has ranged from 1.39 to 3.42. According to the industry distribution chart, Poltreg ranks #510 out of 1227 companies in the Biotechnology industry, placing it in the top 41.6%.
Is Poltreg's PB Ratio too high?
Poltreg's current PB Ratio of 2.44 is near median its 10-year median of 2.51. Over the past 10 years, this metric has ranged from a low of 1.39 to a high of 3.42. The Biotechnology industry median PB Ratio is 2.95. Poltreg's value of 2.44 is 17.3% below this industry median. Based on the distribution chart, Poltreg ranks #510 out of 1227 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Poltreg has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Poltreg's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Poltreg ranks #510 out of 1227 companies for PB Ratio. This puts Poltreg in the upper half of its industry. The industry median PB Ratio is 2.95. Poltreg's value of 2.44 is 17.3% below this benchmark. Historically, Poltreg's own PB Ratio has ranged from 1.39 to 3.42 over the past decade. While the company's 10-year median is 2.51 vs. the industry median of 2.95, Poltreg has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.95, based on 1,227 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Poltreg's current PB Ratio of 2.44 is 17.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Poltreg and its competitors. For the Biotechnology industry, the median PB Ratio is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Poltreg's current PB Ratio is 2.44, which is near median its own 10-year median of 2.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poltreg stock overvalued right now?
Based on GuruFocus' analysis, Poltreg (WAR:PTG) is currently considered Significantly Overvalued. The stock's GF Value™ is zł14.20, compared to a current price of zł19.15 — trading 34.9% above its estimated fair value. The current PB Ratio is 2.44, which is near median its 10-year median of 2.51 and 17.3% below the Biotechnology industry median of 2.95. Poltreg's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Poltreg (WAR:PTG), the current PB Ratio is 2.44 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Poltreg (WAR:PTG) Overvalued in 2026?
Based on GuruFocus' analysis, Poltreg stock appears to be overvalued.
The current stock price of zł19.15 is trading 34.9% above its estimated GF Value™ of zł14.20.
GuruFocus considers Poltreg to be Significantly Overvalued.
Key valuation signals for WAR:PTG:
PB Ratio: 2.44 (near median its 10-year median of 2.51)
GF Value™: zł14.20 vs. price of zł19.15 (34.9% above fair value)
Industry Position: 17.3% below the Biotechnology median (#510 of 1227)
No single metric tells the full story. See the WAR:PTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Poltreg SA is a biotechnology company at the clinical stage developing an innovative generation of medicines using T-regulatory cells (TREGS) in the treatment of autoimmune diseases.
46GF Score
Get the complete analysis for WAR:PTG
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PTG has been successfully added to your 
